Human immunodeficiency virus (HIV) is a species of retrovirus that specifically infects humans. Retroviruses invade host cells and alter the genome of that cell by inserting a copy of its RNA genome. Image Credit: AS photostudio/Shutterstock.com If left untreated, the HIV virus causes acquired immunodeficiency syndrome (AIDS), a progressive failure of the immune system, leading to death from infection or […]
Continue reading »
Antibiotics can only treat illnesses caused by bacteria. However, there is a common misconception that they can also treat viral conditions, such as colds, bronchitis, and flu. This miseducation of the public, surrounding the use of antibiotics, in addition to improper prescribing from physicians, has lead to increased antibiotic resistance in the population, which threatens to reduce the efficacy of […]
Continue reading »
KHN chief Washington correspondent Julie Rovner discussed the Supreme Court’s decision to hear a challenge in an abortion case from Mississippi on Newsy on Tuesday. Click here to watch Rovner on Newsy KHN freelancer Sara Reardon discussed allegations by a rail company that a clinic in Libby, Montana, is defrauding Medicare by overdiagnosing asbestos-related diseases on Montana Public Radio on May […]
Continue reading »
A new episode of our podcast, “Show Me the Science,” has been posted. At present, these podcast episodes are highlighting research and patient care on the Washington University Medical Campus as our scientists and clinicians confront the COVID-19 pandemic. After recently announcing that vaccinated people could safely take off their masks outdoors and gather in small groups with other vaccinated […]
Continue reading »
tezepelumab Amgen Announces Tezepelumab Biologics License Application Submitted To U.S. FDA THOUSAND OAKS, Calif., May 10, 2021 /PRNewswire/ — Amgen (NASDAQ:AMGN) today announced its partner AstraZeneca (NASDAQ:AZN) submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for tezepelumab, a potential first-in-class medicine in severe asthma. The submission is supported by positive clinical trial results from the PATHFINDER clinical program including the pivotal NAVIGATOR Phase […]
Continue reading »
Colorectal cancer diagnoses have increased among people under age 50 in recent years, and researchers are seeking reasons why. A new study led by Washington University School of Medicine in St. Louis has found a link between drinking sugar-sweetened beverages and an increased risk of developing colorectal cancer in women under age 50. The findings suggest that heavy consumption of […]
Continue reading »
Communal Spirit Prince Harry recently delivered a powerful message to farmers in Australia in which he addressed the issue of mental health. Preceding the commencement of Invictus Games, Prince Harry and Meghan, his wife, paid a visit to a part of Dunno where the locals had been having issues with unfavorable climatic conditions. Prince Harry, while delivering his speech encouraged the people to be on the lookout for their fellow community members. Prince Harry acknowledged […]
Continue reading »
mobocertinib Takeda Announces U.S. FDA Grants Priority Review for New Drug Application for Mobocertinib (TAK-788) as a Treatment for EGFR Exon20 Insertion+ Metastatic Non-Small Cell Lung Cancer CAMBRIDGE, Mass. & OSAKA, Japan–(BUSINESS WIRE) April 27, 2021– Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced that the U.S. Food and Drug Administration (FDA) has granted priority review for the company’s New […]
Continue reading »
Current estimates indicate that over 1 billion of the world’s poorest people are affected by neglected tropical diseases (NTDs). NTDs are typically found in areas of extreme poverty within Africa, Asia, and Latin America. Image Credit: bsd/Shutterstock.com Introduction By definition, a neglected tropical disease is a disease that causes significant illness for people around the world. There is a direct […]
Continue reading »
As the COVID-19 pandemic has progressed, it has become clear that many survivors — even those who had mild cases — continue to manage a variety of health problems long after the initial infection should have resolved. In what is believed to be the largest comprehensive study of long COVID-19 to date, researchers at Washington University School of Medicine in […]
Continue reading »